Live Breaking News & Updates on Prnewswire Biolinerx Ltd

Stay updated with breaking news from Prnewswire biolinerx ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)

BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Ella Sorani , Moran Meir , John Lacey , Jude Children Research Hospital , Biolinerx Ltd , Us Food Drug Administration , Exchange Commission On , Prnewswire Biolinerx Ltd , Washington University School Of Medicine , Jude Children Research Hospital Inc , Lifesci Advisors , Jude Children , Research Hospital , Chief Development Officer , Washington University School , Drug Administration , Sickle Cell Disease Stem Mobilization , Apheresis Using Motixafortide , Private Securities Litigation Reform Act , Exchange Commission , Sci Advisors ,

BioLineRx to Report First Quarter 2024 Results on May 28, 2024

Management to Hold Conference Call at 8:30 a.m. EDT
TEL AVIV, Israel, May 22, 2024 /PRNewswire/ BioLineRx Ltd. , a commercial stage biopharmaceutical company pursuing life-changing therapies in. ....

United States , Philip Serlin , Moran Meir , John Lacey , Prnewswire Biolinerx Ltd , Lifesci Advisors , Biolinerx Ltd , Hold Conference Call , Chief Executive , Sci Advisors ,

BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification

BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Tel Aviv , United States , John Lacey , Moran Meir , Nasdaq Stock Market , Tel Aviv Stock Exchange , Company American Depositary Shares Adss , Lifesci Advisors , Exchange Commission On , Prnewswire Biolinerx Ltd , Company Nasdaq , Company Adss , Biolinerx Ltd , Nasdaq Listing Rules , Nasdaq Capital Market , American Depositary Shares , Listing Rule , Nasdaq Listing Rule , Private Securities Litigation Reform Act , Exchange Commission , Sci Advisors ,

BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement

/PRNewswire/ BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare. ....

United States , Gloria Biosciences , Philip Serlin , Moran Meir , John Lacey , Washington University School Of Medicine , Lifesci Advisors , Biolinerx Ltd , Exchange Commission On , Columbia University , Prnewswire Biolinerx Ltd , Growth Lending , Kreos Capital , Chief Executive Officer , Washington University School , Panc Phase , Private Securities Litigation Reform Act , Exchange Commission , Sci Advisors ,

BioLineRx Announces $6 Million Registered Direct Offering

BioLineRx Announces $6 Million Registered Direct Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , John Lacey , Moran Meir , Philip Serlin , Biolinerx Adss , Jonestrading Institutional Services , Company American Depositary Shares Adss , Biolinerx Ltd , Prnewswire Biolinerx Ltd , Exchange Commission , Lifesci Advisors , American Depositary Shares , Chief Executive Officer , Equity Capital Markets , Private Securities Litigation Reform Act , Annual Report , Sci Advisors ,